Development of an orally bioavailable covalent STING inhibitor
Preprint
- 3 October 2024
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
Pharmacological inhibition of cGAS-STING-controlled innate immune pathway is an emerging therapeutic strategy for a myriad of inflammatory diseases, including autoimmune disease, ulcerative colitis, non-alcoholic fatty liver disease and aging-related neurodegeneration. Here we report GHN105 as an orally bioavailable covalent STING inhibitor. Late-stage diversification of the briarane-type diterpenoid excavatolide B allowed the installation of solubility-enhancing functional groups while enhancing its activity as a covalent STING inhibitor against multiple human STING variants, including the S154 variant responsible for a genetic autoimmune disease. Selectively engaging the membrane-proximal Cys91 residue of STING, GHN105 dose-dependently inhibited cGAS-STING signaling and type I interferon responses in cells and in vivo. Orally administered GHN105 exerted marked therapeutic efficacy and reversed key pathological features in a delayed-treatment acute colitis mouse model. Notably, we also showed that GHN105 covalently engaged STING in the colon tissues. Our study provided proof of concept that synthetic briarane analog GHN105 serves as a safe and orally active covalent STING inhibitor. With a growing number of chronic inflammatory diseases linked to aberrant STING activation, orally bioavailable STING inhibitors would benefit patients by lowering the infection risk from frequent injections while allowing long-term systemic administration.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunityCell, 2024
- Inhibiting the cGAS-STING Pathway in Ulcerative Colitis with Programmable MicellesACS Nano, 2024
- Development of LB244, an Irreversible STING AntagonistJournal of the American Chemical Society, 2023
- 4-Octyl itaconate restricts STING activation by blocking its palmitoylationCell Reports, 2023
- Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer ImmunotherapyChemical Reviews, 2022
- An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T CellsCell, 2020
- STING-Dependent Signaling Underlies IL-10 Controlled Inflammatory ColitisCell Reports, 2017
- STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory DiseaseCell Host & Microbe, 2015
- Briaexcavatolides K−N, New Briarane Diterpenes from the Gorgonian Briareum excavatumJournal of Natural Products, 2001
- Ordered Recruitment of Chromatin Modifying and General Transcription Factors to the IFN-β PromoterCell, 2000